Creation of promising ligand, for example a dual PPARα/PPARγ agonist (glitazar class) [99, 100], could beuseful to treat insulin sensitivity, atherosclerotic vascular, andfertility in PCOS women. This evidence concerns the gene PPARG and polycystic ovary syndrome.